Category: Oncology/Hematology
Global Oncology/Hematology
-
2024 World Molecular Diagnostics Market in 92 Countries: 2023 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing ... Read More
-
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Global Forecast to 2029
... & non-stem cell therapies market is projected to reach USD 22.2 billion by 2029 from USD 5.5 billion in 2024, at a CAGR of 32.3% during the forecast period. The growth of this market is ... Read More
-
3D Cell Culture Market Forecasts to 2030 - Global Analysis By Product (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting and Other Products), Application (Cancer Research, Stem Cell Research and Tissue Engineering, Drug Development and Toxicity Testing, Clinical Applications, Regenerative Medicine and Other Applications), End User and By Geography
... Testing, Clinical Applications, Regenerative Medicine and Other Applications), End User and By Geography According to Stratistics MRC, the Global 3D Cell Culture Market is accounted for $2.78 billion in 2024 and is expected to reach ... Read More
-
Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 5.14 billion in 2024, at a CAGR 9.95% to reach USD 9.09 billion by 2030. Pancreatic cancer therapeutics encompass a variety of treatment modalities used to manage and combat ... Read More
-
Cancer/Tumor Profiling Market by Technology (Immunoassays, In-Situ Hybridization, Mass Spectrometry), Biomarker Type (Genomic Biomarker, Protein Biomarker), Cancer Type, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 12.77 billion in 2024, at a CAGR 18.74% to reach USD 35.94 billion by 2030. Cancer/tumor profiling is a laboratory method that analyzes specific proteins, genes, and other molecules ... Read More
-
Cancer Biomarkers Market by Biomarker Type (Genetic, Protein), Cancer Type (Blood Cancer, Breast Cancer, Colorectal Cancer), Technology, Application, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 31.23 billion in 2024, at a CAGR 10.71% to reach USD 57.75 billion by 2030. Cancer biomarkers are substances or processes that can be measured in parts of ... Read More
-
Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 7.05 billion in 2024, at a CAGR 27.15% to reach USD 30.48 billion by 2030. Gene therapy is a medical procedure that introduces, alters, or corrects genetic ... Read More
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Next-Generation Cancer Diagnostics Market by Technology (Clustered Regularly Interspaced Short Palindromic Repeats Diagnostics, DNA Microarrays, Lab-on-a-Chip & Reverse Transcriptase-PCR), Cancer Type (Bladder Cancer, Breast Cancer, Cervical Cancer), Application, Function - Global Forecast 2024-2030
... Cancer Diagnostics Market size was estimated at USD 9.77 billion in 2023 and expected to reach USD 12.02 billion in 2024, at a CAGR 24.12% to reach USD 44.36 billion by 2030. The next-generation cancer ... Read More
-
Tumor Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Tumor Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others), By Technology (Microarray, Real-Time Quantitative, Polymerase Chain Reaction (Q-PCR), Others), By Product (Consumables, Instrument, Software & Services), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others), and By Region, 2019-2029F
... Others), By Product (Consumables, Instrument, Software & Services), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others), and By Region, 2019-2029F Global Tumor ... Read More
-
Global Laboratory Developed Tests Market Size study, by Technology Outlook (Immunoassays, Hematology & Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Others), by Application Outlook (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Other Diseases) and Regional Forecasts 2022-2032
... Regional Forecasts 2022-2032 Global Laboratory Developed Tests Market is valued at approximately USD 12.36 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.21% over the forecast period ... Read More
-
Procarbazine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... of US$ 102.83 million by 2030 with a CAGR of 3.20% during the forecast period 2024-2030. North American market for Procarbazine was valued at $ 32.71 million in 2023 and will reach $ 40.48 million ... Read More
-
Cancer Biomarker Global Market Opportunities And Strategies To 2033
... Risk Assessment4) By Cancer Type: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach CancerCovering: Roche Diagnostics; Novartis AG; Illumina; Hologic Inc.; Thermo ... Read More
-
Tumor Ablation Market Size, Share & Trends by Technology (Radiofrequency, Microwave, Laser, IRE, HIFU, Cryoablation), Product (Generators, Probes), Mode (Surgical, Laparoscopic, Percutaneous), Cancer (Liver, Lung, Bone), End User (Hospitals, Clinic) & Region - Global Forecast to 2029
... to 2029 The global tumor ablation market is projected to reach USD 1.4 billion by 2029 from USD 0.8 billion in 2024, at a CAGR of 10.0% from 2024 to 2029. Aging population, coupled with ... Read More
-
Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Global Forecast to 2029
... The preclinical imaging market is projected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR 5.9% during the forecast period. The market growth is mainly driven by factors ... Read More
-
Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer); By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2024 - 2032
... By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2024 - 2032 The global cancer immunotherapy market size is expected to reach USD 261.39 billion by 2032 according to a new study by Polaris ... Read More
-
Oncology Biosimilars Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Class (Monoclonal Antibodies, G-CSF, Hematopoietic Agents, Others), By Type of Cancer (Breast Cancer, Lung Cancer, Stomach Cancer, Prostate Cancer, Cervical Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F
... Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F Global Oncology Biosimilars Market was valued at USD 3.27 Billion in 2023 and is anticipated ... Read More
-
2024 Global Immunodiagnostics Market Database for the US, Europe, Japan - 2023 Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests
... from LeadingMarketResearch.com provides information and analysis not available from any other published source . This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 clinical chemistry, TDM, endocrine, ... Read More
-
Global Lung Cancer Therapeutics Market 2024-2028
... lung cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Global Forecast to 2029
... market is projected to reach USD 238.3 billion by 2029 from USD 163.5 billion in 2024, at a CAGR of 7.8% during the forecast period of 2024 to 2029. The growth of this market can ... Read More
-
Antisense and RNAi Therapeutics Market – Technology (RNA Interference, Antisense RNA), Route of Administration (Intrathecal, Intravenous, Subcutaneous), Application (Neurodegenerative, Cancer, Skin, Genetic Disorders) – Global Forecast (2024 – 2032)
... will grow at an 18.2% CAGR during 2024 and 2032, propelled by growing research and development coupled with the expansion of clinical trials. Continuous R&D efforts lead to the discovery of innovative therapies and improvements ... Read More
-
Cancer Diagnostics Global Market Opportunities And Strategies To 2033
... Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach Cancer3) By End User: Cancer Research Institutes; Diagnostic Laboratories; HospitalsCovering: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Illumina Inc.; Hologic Inc. Cancer Diagnostics Global ... Read More
-
2024 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines ... Read More
-
Digital X-ray Market by Portability (Fixed, Portable), Applications (Orthopedic, Dental, Diagnostic, Cancer, Pediatric), Technology (Direct, Computed), System (Retrofit, New), End Users, Price Range, Type, and Region - Global Forecast to 2029
... market is projected to reach USD 6.6 billion by 2029 from USD 5.4 billion in 2024, at a CAGR of 4.0% from 2024 to 2029. The rising prevalence of chronic diseases, coupled with increasing demand ... Read More
-
Personalized Medicine Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Early Detection/Screening, Indication, Treatment Selection, Monitoring), By Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By Region and Competition, 2019-2029F
... 2019-2029F Global Personalized Medicine Biomarkers Market was valued at USD 14.11 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In recent years, ... Read More
Research Assistance
